Cancer-Associated Thrombosis (New Findings in Translational Science, Prevention, and Treatment)
List Price:
$280.00
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Alok A. Khorana, Charles W. Francis
Format:
Hardcover
Pages:
296
Publisher:
CRC Press (September 26, 2007)
Imprint:
CRC Press
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9781420047998
Weight:
24oz
Dimensions:
7" x 10"
File:
TAYLORFRANCIS-TayFran_260907042633416-20260907.xml
Folder:
TAYLORFRANCIS
List Price:
$280.00
Country of Origin:
United States
Pub Discount:
30
Case Pack:
22
As low as:
$266.00
Publisher Identifier:
P-CRC
Discount Code:
H
Overview
Showcasing the expertise of top-tier specialists who contributed to the newly released guidelines for the care of thrombosis in cancer patients, this exciting guide was written and edited by members of the American Society of Clinical Oncology panel, (ASCO), on the prevention and treatment of cancer-associated thrombosis, among others, and provides an authoritative discussion of strategies to effectively implement and interpret the new ASCO/NCCN directives. Standing as the only up-to-date source to readily examine exciting new translational science findings regarding the biology of cancer-associated thrombosis, as well as new clinical recommendations, this guide supplies an authoritative and current discussion of the mechanisms, management, and prevention of cancer-associated thrombosis.
Written alongside the development of the ASCO guidelines in order to fully examine and address the entire breadth of published literature on the topic, this reference explains to specialists how to identify risk factors associated with cancer-associated thrombosis and improve patient outcomes…tracks the development and utilization of low-molecular weight heparins (LMWHs) in the prevention and treatment of cancer-associated thrombosis…contains a summary of the ASCO VTE guidelines by the Co-Chair of the ASCO Panel…offers an executive summary section in each chapter that highlights critical information…provides an at-hand overview of recent translational studies on mechanisms including the linkage of thrombosis with angiogenesis, role of tissue factor, risk assessment, screening, etiology, and emerging therapies.
Written alongside the development of the ASCO guidelines in order to fully examine and address the entire breadth of published literature on the topic, this reference explains to specialists how to identify risk factors associated with cancer-associated thrombosis and improve patient outcomes…tracks the development and utilization of low-molecular weight heparins (LMWHs) in the prevention and treatment of cancer-associated thrombosis…contains a summary of the ASCO VTE guidelines by the Co-Chair of the ASCO Panel…offers an executive summary section in each chapter that highlights critical information…provides an at-hand overview of recent translational studies on mechanisms including the linkage of thrombosis with angiogenesis, role of tissue factor, risk assessment, screening, etiology, and emerging therapies.
